Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Posted by Francis Steltz on Nov 3rd, 2026

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02), Zacks reports. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%.

Bayer Aktiengesellschaft Stock Down 0.3%

BAYRY opened at $13.95 on Tuesday. The company has a market cap of $54.82 billion, a PE ratio of 8.95, a price-to-earnings-growth ratio of 1.94 and a beta of 0.57. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.67 and a current ratio of 1.04. Bayer Aktiengesellschaft has a 1 year low of $7.48 and a 1 year high of $15.23. The firm has a 50 day moving average price of $13.43 and a 200 day moving average price of $12.55.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy”.

Read Our Latest Stock Report on BAYRY

Bayer Aktiengesellschaft Company Profile

(Get Free Report)

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.